Enlivex | Hadassah International

COVID-19 Patients Recover With New Treatment From Hadassah

Early trials of Allocetra™, an experimental drug developed by Prof. Dror Mevorach, head of one of the COVID-19 units at Hadassah Hospital Ein Kerem, have shown great success in treating…

COVID-19

Enlivex Reports Top-Line Results for Allocetra™ in Treating COVID-19

COVID-19

Drug Developed by Hadassah Doctor Helps Severely Ill COVID-19 Patients

Bone-marrow (transplantation)

Enlivex Successfully Completes First Trial for Treatment of Graft-Versus-Host Disease (GVHD)

Genetics

Hadassah International

COVID-19 Patients Recover With New Treatment From Hadassah

COVID-19 Patients Recover With New Treatment From Hadassah

Enlivex Reports Top-Line Results for Allocetra™ in Treating COVID-19

Drug Developed by Hadassah Doctor Helps Severely Ill COVID-19 Patients

Enlivex Successfully Completes First Trial for Treatment of Graft-Versus-Host Disease (GVHD)

From Research to Clinical Care: the Hadassah Medical Center’s Start-Ups